Lin, Y.-C.; Wang, C.-H.; Ling, H.H.; Pan, Y.-P.; Chang, P.-H.; Chou, W.-C.; Chen, F.-P.; Yeh, K.-Y.
Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy. Biomedicines 2022, 10, 388.
https://doi.org/10.3390/biomedicines10020388
AMA Style
Lin Y-C, Wang C-H, Ling HH, Pan Y-P, Chang P-H, Chou W-C, Chen F-P, Yeh K-Y.
Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy. Biomedicines. 2022; 10(2):388.
https://doi.org/10.3390/biomedicines10020388
Chicago/Turabian Style
Lin, Yu-Ching, Cheng-Hsu Wang, Hang Huong Ling, Yi-Ping Pan, Pei-Hung Chang, Wen-Chi Chou, Fang-Ping Chen, and Kun-Yun Yeh.
2022. "Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy" Biomedicines 10, no. 2: 388.
https://doi.org/10.3390/biomedicines10020388
APA Style
Lin, Y.-C., Wang, C.-H., Ling, H. H., Pan, Y.-P., Chang, P.-H., Chou, W.-C., Chen, F.-P., & Yeh, K.-Y.
(2022). Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy. Biomedicines, 10(2), 388.
https://doi.org/10.3390/biomedicines10020388